Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The big plus is as I see it that our product will prove extremely beneficial to OTHER viruses -- we tend to forget this! We are besotted with Covid but there are so many long standing life threatening respiratory illnesses that have been with us for decades which could benefit. I suggest we publicise this to the maximum!
Dying out? So North Korea's concern about their massive Covid outbreak is all a pack of lies? Sadly they are refusing help from S Korea and China as observers are necessary so many will die needlessly. And of course SA where the disease has mutated. Think you are a little out of touch with the real world.
Our forum is a mere shadow of what it used to be apart from a handful of stalwarts trying to keep the flag flying for which I am grateful. However, my other disaster of a share Synairgen (SGN) has lept 40% this morning on an encouraging RNS so there is hope for NCYT and we tend to forget how AIM can surge dramatically on positive news albeit NCYT comes across as an enigma at times. Would it surge 40% on a DHSC settlement -- i wonder...
This is a nightmare and goodness know how long it will take us dig ourselves out of the morass. Looks like being a long disappointing year again as DA is devoid of any charisma and I view his presentations with as much enthusiasm as creosoting my fence.
'The full analysis of the Phase 3 SPRINTER trial data, including some new sub-group analyses, will be submitted for publication in a peer-reviewed journal.'
Could this be The Lancet? They have already been published here. Would add some kudos -- sorely needed!
EXCLUSIVE from NCYT Marketing Dear ...
We are pleased to announce that, for a limited time only, our March 2022 Sales Promotions are live!
• MyGo Bundled Promo
o Buy 1 MyGO Mini S FREE 3 RUO Kits
o Buy 1 MyGo PRO/ESR FREE 6 RUO Kits
• genesig q16 and q32 Bundled Promo
o Buy 1 genesig q16 FREE 1 Easy Kit
o Buy 1 genesig q32 FREE 2 SNPsig SARS-CoV-2 EscapePLEX
• PathFlow Promo
o PathFlow LFT Buy 1 FREE 1
Terms and conditions apply
Get in touch with us today to save more!
Follow on Twitter Follow on LinkedIn
Copyright © 2022, All rights reserved.
Our mailing address is:
Novacyt Group (UK)
Unit 1 Watchmoor Point
Camberley, GU15 3AD
United Kingdom
unsubscribe from all emails update subscription preferences
Hysteria from the usual pathetic culprits this morning trying to fleece genuine shareholders who have the best interests of Synairgen at heart. Do not pander to these sad people but bin them! Heard a programme on Radio 4 the other evening featuring 3 Long Covid sufferers who were previously interviewed a year ago. All three were still suffering 2 years on. One, used to be a marathon runner is now confined to a wheelchair. This is a horrible illness and the breathless side is still frightening after several years although there was some improvement. Some are likely to suffer effects for the rest of their life. I did not appreciate just how many Long Covid sufferers there were in the Uk -- thousands and this must apply to the rest of the world. SNG still has a major role to play if they can get their act together and Covid could be with us for ever and a day. I am holding for sure.
Good idea Saintsmith. DA's last and only presentation to shareholders was, shall we say, not what one would expect from someone in his position. He may have been under the weather and come in from a morning tidyng up his shed but did he leave anyone punching the air with excitement? Hardly! I think shareholders deserve more than this - a lot more as one is left with almost a feeling of distrust and this from a concern which still has so much going for it - we think! I fully support this approach.
Pity we do not (as yet) have a home testing kit and steal a march on the opposition ..... 'As the Northern hemisphere approaches the 2021-2022 flu season, Novacyt has carried out an analysis of recent influenza genome sequences using its specialist bioinformatics surveillance expertise to determine how significant the genetic drift was in the virus from
the previous year. Through this analysis, Novacyt detected significant mutations in published sequences of the influenza B (flu B) virus and developed a new Winterplex™ test to address the new flu B strain for the 2021-2022 winter flu season. The new Winterplex™ test combines flu B, three-gene COVID-19, flu A and RSV assays in a single kit to provide clinicians and laboratories with a comprehensive testing solution. The test is designed for use in central laboratories with open PCR platforms.'
Pity we do not (as yet) have a home testing kit and steal a march on the opposition ..... 'As the Northern hemisphere approaches the 2021-2022 flu season, Novacyt has carried out an analysis of recent influenza genome sequences using its specialist bioinformatics surveillance expertise to determine how significant the genetic drift was in the virus from
the previous year. Through this analysis, Novacyt detected significant mutations in published sequences of the influenza B (flu B) virus and developed a new Winterplex™ test to address the new flu B strain for the 2021-2022 winter flu season. The new Winterplex™ test combines flu B, three-gene COVID-19, flu A and RSV assays in a single kit to provide clinicians and laboratories with a comprehensive testing solution. The test is designed for use in central laboratories with open PCR platforms.'
Page 17 by Ben Spencer - 'Technology existsin which a Lateral Flow Test could give a result not just for Covd but also for flu and RSV, two respiratory viruses that place huge pressure on the NHS each winter. Instead of showing two lines - one control line and a second line for a positive Covidresult - they would have four lines, with one for RSV and one for flu. In the future, anyone with a cough or a cold could take such a test.' He also says that it woud be unwise to dismantle pop up testing cntres and that it would make sense to boost dwindling childhood vaccination rates or repurpose them as cancer screening centres as Britain has one of the worst cancer survival rates in the West because too many tumours are spotted too late etc. ' We tend to be fascinated by our own health and, driven bythis curiosity and a widespread sense of the comon good, and directed by clear guidance, many people would continue to take tests. The diagnostic infrastruture is one of the success stories of the pandemic. It should be harnessed, not thrown away.' Cannot argue with any of this and I imagine Nova could benefit big time but is Boris listening!
So much for his 'retirement'. Wonder if he is still holding on to his last considerable purchase of NCYT at £8 plus! We will never know the real reason behind his departure which was extremely odd to say the least.
RBMInvest. A sobering post with which I largely agree. Many of us have been like ostriches with heads in the sand and far too attached to Nova. I am sure the company will progress further but may take several years. I am in the process of selling half my holding at a 62% horrific loss which is my own fault being too attached to the share and over invested losing most of my life savings. I should have known better. Time to try and recuperate elsewhere. GLA.
Courtesy gggg 2120 from the SNG forum: https://www.bloomberg.com/news/newsletters/2022-01-29/new-u-s-task-force-prepares-for-next-outbreak
It could be any day now but on the other hand we may well have to wait until end of Feb which in my book still comes under Buzz's early 2022 statement. I am extremely guarded in my optimism re potential optimism -- just look at the NCYT debacle and this from a company with £100m in the bank and money still pouring in. I am 60% down. AIM stocks have proved a graveyard for investors numerous times so I suggest folk just be a little wary. For the record, I have invested witth SNG for a year and am not a deramper just someone who urges caution. All that glitters is not necessarlty gold!